Cytos news from FierceVaccines
NewsPfizer teams with Cytos to develop new vaccines
Further bolstering its ambitious vaccine program, Pfizer has teamed up with Cytos Biotechnology to develop, manufacture and commercialize vaccines for a defined number of human diseases. Cytos gains Read more...
Cytos' blood pressure vax data shows new approach
New data from a small human study of Cytos' blood pressure vaccine has stirred Read more...
| Press ReleasesPRESS RELEASE: Presentation of Phase IIa Results for Cytos Biotechnology's Hypertension Vaccine Presentation of Phase IIa Results for Cytos Biotechnology's Hypertension Vaccine at the American Heart Association Scientific Sessions 2007 ZURICH, Switzerland and ORLANDO, Florida, November 6 Read more... |
Get more Cytos coverage at:
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets